The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Defining the spectrum and "overlap" of HER2 aberrations in lung cancers: Associations of HER2 protein overexpression, HER2 amplification, and HER2 mutation.
 
Bob T. Li
Consulting or Advisory Role - Biosceptre International; Roche
 
Dara S. Ross
No Relationships to Disclose
 
Jamie E. Chaft
Honoraria - Dava Oncology
Consulting or Advisory Role - Biodesix; Genentech/Roche; Myriad Genetics; Otsuka
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Meier Hsu
No Relationships to Disclose
 
Severine Kako
No Relationships to Disclose
 
Dara L. Aisner
No Relationships to Disclose
 
Mark G. Kris
Consulting or Advisory Role - ARIAD; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Exelixis; Genentech/Roche; Novartis; Pfizer; Threshold Pharmaceuticals
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst)
 
Marileila Varella-Garcia
No Relationships to Disclose
 
Maria E. Arcila
No Relationships to Disclose